GERM

Amplify Treatments, Testing and Advancements ETF
GERM

Overview Fund Activity
Delisted

GERM was delisted on the 5th of September, 2024.

Back to rankings

24 hedge funds and large institutions have $9.55M invested in Amplify Treatments, Testing and Advancements ETF in 2021 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 9 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
24
Holders Change
-1
Holders Change %
-4%
% of All Funds
0.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
4
Reduced
9
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Goldman Sachs
1
Goldman Sachs
New York
$1.9M
2
WS
2
Wedbush Securities
California
$390K
3
UBS Group
3
UBS Group
Switzerland
$80K
4
LF
4
Lee Financial
Texas
$48K
5
Koshinski Asset Management
5
Koshinski Asset Management
Illinois
$25.8K

Top Sellers

1
G
1
Gainplan
Michigan
$246K
2
Belvedere Trading
2
Belvedere Trading
Illinois
$0
3
Citadel Advisors
3
Citadel Advisors
Florida
$347K
4
Jane Street
4
Jane Street
New York
$220K
5
BFEC
5
Benjamin F. Edwards & Company
Missouri
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
BFEC
26
Benjamin F. Edwards & Company
Missouri
– -$80K -2,000 Closed
ASN
27
Advisory Services Network
Georgia
– -$40K -1,000 Closed
1
2